Cytosorbents CTSO 深 沪
已收盘 09-04 16:00:00 美东时间
0.3501
+0.000
+0.03%
华盛通- 最 高0.3697
- 今 开0.3453
- 成交量 46.23万股
- 最 低 0.3366
- 昨 收 0.35
- 总市值 2200.12万
- 52周最高 1.02
- 市盈率 静 --
- 换手率 0.74%
- 52周最低 0.30
- 委 比 82.34%
- 总股本 6284.27万
- 历史最高 15.24
- 量 比 0.34
- 振 幅 9.46%
- 历史最低 0.09
- 每 手 1
- 风险率 0.18%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多CytoSorbents to execute 1:20 reverse stock split
CytoSorbents (CTSO) plans to implement a one-for-twenty reverse stock split, effective on September 8, 2026. The reverse stock split is intended to, among other things, increase the per-share trading ...
09-03 19:13
CytoSorbents Announces Reverse Stock Split
Reverse Stock Split Previously Approved by Shareholders; Intended to Support Compliance with Nasdaq's $1.00 Minimum Bid Price Requirement Expected to Become Effective and Trade on Split-Adju...
09-03 19:00
Cytosorbents Advances Toward Operating Cash Flow Breakeven
Cytosorbents ( ($CTSO) ) has provided an update. On August 6, 2026, CytoSorbent...
08-08 04:58
Transcript: CytoSorbents Q1 2026 Earnings Conference Call
CytoSorbents (NASDAQ:CTSO) reported first-quarter financial results on Wednesda...
05-14 05:36
CytoSorbents Q1 Adj. EPS $(0.05) Beats $(0.06) Estimate, Sales $8.864M Miss $9.363M Estimate
CytoSorbents (NASDAQ:CTSO) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.06) by 0 percent. This is a 16.67 percent increase over losses of $(0.06) per share from the same
05-14 04:01
Earnings Scheduled For May 13, 2026
Companies Reporting Before The Bell • Similarweb (NYSE:SMWB) is estimated to re...
05-13 19:11
CytoSorbents Receives Nasdaq Extension to Regain Compliance
An update from Cytosorbents ( ($CTSO) ) is now available. On April 1, 2026, Cyt...
04-02 19:42
电话会总结 ｜ Cytosorbents(CTSO)2025财年Q4业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Cytosorbents业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **营收表现：** - 2025年全年总收入3,710万美元，同比增长4%，创下核心产品销售记录 - Q4收入920万美元，同比增长1%，但按固定汇率计算下降8% - 德国以外直接国际销售860万美元，同比增长13% - 经销商销售1,650万美元，同比增长11.4% - 德国销售1,180万美元，同比下降10% **盈利能力：** - 全年毛利率71%，Q4毛利率74%，显示制造效率提升 - 全年运营亏损1,470万美元，同比改善10%（2024年为1,650万
03-27 12:16
